Cannabis groups are once again highlighting the need for reform in the UK cannabis industry, following the release of a new report from Maple Tree Consultants and Mackrell Solicitors.
The study of patient data found that less than 40 percent of medical cannabis patients over the age 50 have had such discussions with their doctor.
Alisia Ratliff, CEO of Victus Capital Ventures, distils the key points of solvent recovery in cannabis extraction.
A new technology developed by researchers at the University of California Davis promises to fast-track the development of compounds that could exploit psychedelics’ therapeutic action without hallucinogenic side effects.
What factors should an extractor consider when selecting the plant material they’ll extract from? Analytical Cannabis asked Lydia Abernethy, former senior science consultant at Steep Hill Labs, just that.
Heather Despres, director of the Patient Focused Certification program at the non-profit Americans for Safe Access, outlines how extractors can use existing frameworks in federal law to implement safe practices and future-proof against possible legislative changes.
If vast, industrial warehouses embody the future of CBD extraction, what does that future look like in detail? Analytical Cannabis took a virtual tour of such a facility to find out.